A detailed history of Centiva Capital, LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 6,465 shares of AMPH stock, worth $252,910. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,465
Previous 23,575 72.58%
Holding current value
$252,910
Previous $943,000 66.81%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.99 - $50.09 $632,898 - $857,039
-17,110 Reduced 72.58%
6,465 $313,000
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $911,173 - $1.03 Million
23,575 New
23,575 $943,000
Q2 2023

Aug 14, 2023

BUY
$35.77 - $58.38 $209,075 - $341,231
5,845 Added 109.38%
11,189 $643,000
Q1 2023

May 15, 2023

BUY
$27.99 - $37.92 $149,578 - $202,644
5,344 New
5,344 $200,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.